We are live on ! Find out more
GMED icon

Globus Medical
GMED

120 hedge funds and large institutions have $899M invested in Globus Medical in 2013 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 55 increasing their positions, 32 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 8

72% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 32

49% more call options, than puts

Call options by funds: $318K | Put options by funds: $213K

36% more capital invested

Capital invested by funds: $661M → $899M (+$238M)

18.06% more ownership

Funds ownership: 60.73% → 78.79% (+18%)

12% more funds holding

Funds holding: 107 → 120 (+13)

Holders
120
Holders Change
+13
Holders Change %
+12.15%
% of All Funds
3.89%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
22
Increased
55
Reduced
32
Closed
8
Calls
$318K
Puts
$213K
Net Calls
+$105K
Net Calls Change
+$34K

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$45.3M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$24.2M
3
DM
Deerfield Management
New York
+$20.7M
4
CIP
Champlain Investment Partners
Vermont
+$17.4M
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$14.1M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$17.1M
2
CII
CR Intrinsic Investors
Connecticut
-$6.2M
3
Neuberger Berman Group
Neuberger Berman Group
New York
-$4.92M
4
RA
Royce & Associates
New York
-$2.92M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$1.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
MLICM
76
Metropolitan Life Insurance Company (MetLife)
New York
$769K – – –
Swiss National Bank
77
Swiss National Bank
Switzerland
$761K -$164K -9,500 -18%
CS
78
Credit Suisse
Switzerland
$684K -$838K -48,427 -55%
AIG
79
American International Group
New York
$639K +$519K +30,016 +455%
ProShare Advisors
80
ProShare Advisors
Maryland
$602K +$597K +34,507 New
MWNA
81
Marshall Wace North America
New York
$540K -$680K -39,317 -56%
VOYA Investment Management
82
VOYA Investment Management
Georgia
$497K – – –
BA
83
BlackRock Advisors
Delaware
$439K +$5.57K +322 +1%
TAM
84
Tocqueville Asset Management
New York
$437K – – –
PP
85
PDT Partners
New York
$403K +$169K +9,781 +74%
Commonwealth Equity Services
86
Commonwealth Equity Services
Massachusetts
$365K -$42.8K -2,475 -11%
JP Morgan Chase
87
JP Morgan Chase
New York
$326K +$323K +18,653 New
First Trust Advisors
88
First Trust Advisors
Illinois
$315K +$129K +7,481 +71%
Principal Financial Group
89
Principal Financial Group
Iowa
$297K -$19.3K -1,116 -6%
UBS AM
90
UBS AM
Illinois
$285K – – –
WMSA
91
Weiss Multi-Strategy Advisers
New York
$276K +$274K +15,830 New
PPA
92
Parametric Portfolio Associates
Washington
$273K -$460K -26,604 -63%
BNP Paribas Financial Markets
93
BNP Paribas Financial Markets
France
$263K -$106K -6,109 -29%
Citadel Advisors
94
Citadel Advisors
Florida
$249K +$247K +14,244 New
LPL Financial
95
LPL Financial
California
$248K -$22.5K -1,300 -8%
BUB
96
BBVA USA Bancshares
Texas
$242K – – –
Tudor Investment Corp
97
Tudor Investment Corp
Connecticut
$232K +$27.7K +1,600 +14%
U
98
UBS
Switzerland
$197K -$501K -28,924 -72%
GCP
99
GSA Capital Partners
United Kingdom
$189K -$57.1K -3,301 -23%
Millennium Management
100
Millennium Management
New York
$183K -$95.2K -5,500 -34%
2 3
4
5 6

GMED Hedge Fund Activity: Q3 2013 in Review

120 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q3 2013, worth a combined $899M — up 36% from $661M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new GMED positions and 8 closed out — a net gain of 14 holders — while 55 added to existing stakes and 32 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $45.3M. The largest seller was Goldman Sachs, cutting an estimated $17.1M.

  • 120 institutional investors held Globus Medical (GMED) as of Q3 2013, up from 107 in Q2 2013.
  • Funds reported $899M of Globus Medical stock for Q3 2013, up 36% quarter-over-quarter.
  • 22 funds opened new Globus Medical positions in Q3 2013 and 8 closed out, a net change of +14 holders.
  • The largest Globus Medical buyer in Q3 2013 was Wellington Management Group, an estimated $45.3M added.
  • The largest Globus Medical seller in Q3 2013 was Goldman Sachs, an estimated $17.1M sold.

Based on aggregated 13F filings for Q3 2013.